Patients infected with SARS-CoV-2 develop protective immune responses, mediated by virus-specific T cells and antibodies, shortly after the infection. There is concern, however, that immunity does not persist over time, which may translate into severe COVID-19 upon re-infection.
In the July, 12 issue of Proceedings of the National Academy of Sciences (PNAS), Anna Martner and co-authors at University of Gothenburg report two main findings. First, several variants of virus-specific T cells became detectable in blood shortly after COVID-19, but strikingly disappeared after 10-12 weeks.
However, a group of highly specialized T cells, designed to facilitate elimination of infected cells, remained active in the blood of all previously SARS-CoV-2-infected patients. These T cells did not disappear or wane even at long follow-up.
The findings may explain the reduced risk of severe disease and mortality among patients who have become re-infected with SARS-CoV-2.
Scientists at the University of Gothenburg and Sahlgrenska University Hospital collected 81 blood samples from hospital staff members who had contracted mild COVID-19 in the first year of the pandemic and uninfected controls. The researchers studied T cell reactivity to an inner part of SARS-CoV-2 (the virus nucleocapsid) thus capturing T cell responses that only occur after a natural infection.
The blood samples were exposed to more than 100 peptides from the nucleocapsid portion of SARS-CoV-2 virus. The researchers then analyzed which T cell mediators (cytokines) were produced by blood cells to determine the longevity of T cell reactivity after the infection.
It was observed that a subgroup of specialized T cells (Th1 cells) that promote destruction of virus-infected cells were active for at least 20 months after natural COVID-19. The infected patients also harbored several other types of T cells that reacted with SARS-CoV-2. These latter T cells disappeared from blood approximately 2 months after recovery from infection.
“While certain subsets of T cells disappear shortly after infection, highly specialized T cells (T helper 1 cells) remain stably present in blood to suggest that a vital aspect of protective immunity is functional years after COVID-19,” says Anna Martner, Associate Professor of immunology at the Sahlgrenska Academy. These results may explain why re-infection with SARS-CoV-2 only rarely translates into severe COVID-19.
Story Source:
Materials provided by University of Gothenburg. Note: Content may be edited for style and length.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
